Astrana Health, Inc.
ASTH
$40.81
$3.027.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 52.43% | |||
| Total Other Revenue | 2.43% | 0.98% | |||
| Total Revenue | 0.77% | 1.53% | |||
| Cost of Revenue | 1.06% | 0.45% | |||
| Gross Profit | -1.63% | 11.26% | |||
| SG&A Expenses | -11.46% | 0.18% | |||
| Depreciation & Amortization | 0.46% | -5.62% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.24% | 0.33% | |||
| Operating Income | 17.91% | 65.44% | |||
| Income Before Tax | 38.06% | 162.58% | |||
| Income Tax Expenses | 33.14% | 596.82% | |||
| Earnings from Continuing Operations | 40.52% | 100.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -1.38% | 331.79% | |||
| Net Income | 36.73% | 140.64% | |||
| EBIT | 17.91% | 65.44% | |||
| EBITDA | 11.85% | 31.16% | |||
| EPS Basic | 36.01% | 142.41% | |||
| Normalized Basic EPS | 14.61% | 1,396.70% | |||
| EPS Diluted | 37.93% | 137.90% | |||
| Normalized Diluted EPS | 13.56% | 1,398.90% | |||
| Average Basic Shares Outstanding | 0.54% | -0.77% | |||
| Average Diluted Shares Outstanding | 1.48% | -0.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.33% | -0.98% | |||